CEACAM5 and colorectal carcinoma: CRC surveillance currently relies upon serial radiological investigations (usually computed tomography (CT), which subjects patients to significant cumulative radiation doses and a not insignificant false positive rate) (Chao and Gibbs, 2009), and measurement of blood carcinoembryonic antigen (CEA) levels.